RADU, CLAUDIA-MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.893
EU - Europa 696
AS - Asia 562
SA - Sud America 5
AF - Africa 3
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.892
CN - Cina 307
IT - Italia 228
SG - Singapore 183
DE - Germania 111
FI - Finlandia 102
SE - Svezia 97
GB - Regno Unito 56
VN - Vietnam 53
FR - Francia 39
UA - Ucraina 25
NL - Olanda 11
IE - Irlanda 10
IN - India 10
CH - Svizzera 6
BR - Brasile 4
ES - Italia 3
AU - Australia 2
EU - Europa 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
LU - Lussemburgo 2
BE - Belgio 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
SZ - Regno dello Swaziland 1
ZA - Sudafrica 1
Totale 7.164
Salva come PNG Salva come JPEG
Città #
Fairfield 1.000
Woodbridge 684
Chandler 540
Ashburn 489
Ann Arbor 466
Houston 393
Seattle 390
Wilmington 340
Cambridge 327
Singapore 138
Jacksonville 126
San Diego 102
Princeton 98
Padova 94
Beijing 91
Des Moines 68
Medford 68
Helsinki 55
Dong Ket 53
Boardman 47
Roxbury 44
Nanjing 30
Santa Clara 28
London 20
Milan 19
Shenyang 17
Falls Church 14
Nanchang 14
New York 14
Guangzhou 12
Hebei 11
Jinan 11
Norwalk 10
Nürnberg 10
Los Angeles 9
Bologna 8
Changsha 8
Dallas 8
Hefei 8
Chicago 7
Legnaro 7
Cagliari 6
Dublin 6
Jiaxing 6
Kharkiv 6
Kilburn 6
Ogden 6
Tianjin 6
Redwood City 5
Washington 5
Basel 4
Ferentino 4
Kunming 4
Taiyuan 4
Chiswick 3
Detroit 3
Gunzenhausen 3
Indiana 3
Lappeenranta 3
Martinsicuro 3
Ningbo 3
Rockville 3
Shanghai 3
Tivoli 3
Afragola 2
Amsterdam 2
Atlanta 2
Bassano Del Grappa 2
Borås 2
Boston 2
Brentwood 2
Capriate San Gervasio 2
Cardano al Campo 2
Dearborn 2
Frankfurt am Main 2
Haikou 2
Hangzhou 2
Hong Kong 2
Luxembourg 2
Madrid 2
Munich 2
Orange 2
Paris 2
Piacenza 2
Portland 2
Pune 2
Rocca d'Arazzo 2
Southwark 2
Stockholm 2
São Paulo 2
Taizhou 2
Tokyo 2
Zhengzhou 2
Asir 1
Auckland 1
Belluno 1
Berlin 1
Bern 1
Bilbao 1
Brussels 1
Totale 6.041
Salva come PNG Salva come JPEG
Nome #
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 193
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 191
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 176
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 169
Dynamics of circulating microparticles in obesity after weight loss 147
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 141
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 132
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 126
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 125
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 123
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 121
Microparticles as biomarkers of venous thromboembolic events 120
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 120
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 117
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 113
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 112
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 112
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 112
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 109
Platelet factor V levels in moderate to severe congenital factor V deficiency. 109
Studies on coagulation incompatibilities for xenotransplantation. 107
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 105
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 104
Effects of long-term administration of recombinant human protein C in xenografted primates. 104
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 103
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 102
MP062 EXPLORING ALBUMIN UPTAKE IN HUMAN PODOCYTES: A POSSIBLE INVOLVEMENT FOR THE TUBULAR UPTAKE MACHINERY 100
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 99
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 99
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 96
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 96
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 95
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 95
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 95
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 91
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 88
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 87
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 85
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 84
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 84
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 83
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 82
Inherited thrombophilia and venous thromboembolism 82
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 82
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 80
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 80
The haemostatic system in acromegaly: a single-centre case–control study 80
Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. 78
The aggressive EpCAM+CD45+ phenotype in serous epithelial ovarian cancer 77
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 76
Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation. 75
Circulating microparticles in carriers of prothrombin G20210A mutation. 74
Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma 72
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma 72
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 72
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 72
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 69
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 66
[Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases]. 65
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 65
Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation 61
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 61
Albumin uptake in human podocytes: A possible role for the cubilin-amnionless (CUBAM) complex 61
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 60
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 59
Levels of circulating microparticles in septic shock and sepsis-related complications: A case-control study 57
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 56
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings.   56
Sounds Stimulation on In Vitro HL1 Cells: A Pilot Study and a Theoretical Physical Model 52
Thrombin generation profile in cynomolgus monkey recipients of porcine neuronal xenograft 50
Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. 49
Evaluation of necroptosis related genes RIPK1, RIPK3 and MLKL-p immunogenicity in hepatocellular carcinoma 48
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 46
Coagulation profile in cynomolgus monkey recipients of porcine neuronal xenograft: a preliminary study 43
CHARACTERIZATION OF CIRCULATING MICROPARTICLES DURING NORMAL PREGNANCY 42
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 41
Exploring albumin uptake in human podocytes: a possible involvement of the tubular endocytic machinery 39
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules 38
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 34
Study of the origin of platelets coagulation protein S by human megakaryocyte cultures and characterization of platelets protein S in patients with inherited protein S deficiency 34
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 33
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation 31
Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma 27
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 26
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 12
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 12
Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin? 9
Increased Soluble Interleukin 6 Receptors in Fabry Disease 9
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 8
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 6
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 5
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 4
Totale 7.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.728
article - articoli 26.833
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.163 0 0 0 91 135 101 144 171 200 174 80 67
2020/20211.368 49 89 107 96 81 55 52 153 152 223 132 179
2021/20221.244 52 73 160 92 95 103 39 170 78 26 101 255
2022/20231.043 175 115 31 143 174 115 6 71 136 11 51 15
2023/2024547 31 78 57 56 39 67 43 43 18 25 40 50
2024/2025326 5 156 102 63 0 0 0 0 0 0 0 0
Totale 7.258